NO20005128D0 - Composition comprising L-carnitine or an alkanoyl-L-carnitine and NADH and / or NADPH - Google Patents

Composition comprising L-carnitine or an alkanoyl-L-carnitine and NADH and / or NADPH

Info

Publication number
NO20005128D0
NO20005128D0 NO20005128A NO20005128A NO20005128D0 NO 20005128 D0 NO20005128 D0 NO 20005128D0 NO 20005128 A NO20005128 A NO 20005128A NO 20005128 A NO20005128 A NO 20005128A NO 20005128 D0 NO20005128 D0 NO 20005128D0
Authority
NO
Norway
Prior art keywords
carnitine
nadh
nadph
alkanoyl
composition
Prior art date
Application number
NO20005128A
Other languages
Norwegian (no)
Other versions
NO20005128L (en
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of NO20005128D0 publication Critical patent/NO20005128D0/en
Publication of NO20005128L publication Critical patent/NO20005128L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO20005128A 1998-04-17 2000-10-12 Composition comprising L-carnitine or an alkanoyl-L-carnitine and NADH and / or NADPH NO20005128L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98RM000238A IT1299161B1 (en) 1998-04-17 1998-04-17 COMPOSITION INCLUDING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND NADH AND / OR NADPH
PCT/IT1999/000088 WO1999053921A1 (en) 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph

Publications (2)

Publication Number Publication Date
NO20005128D0 true NO20005128D0 (en) 2000-10-12
NO20005128L NO20005128L (en) 2000-12-18

Family

ID=11405812

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005128A NO20005128L (en) 1998-04-17 2000-10-12 Composition comprising L-carnitine or an alkanoyl-L-carnitine and NADH and / or NADPH

Country Status (17)

Country Link
EP (1) EP1071424A1 (en)
JP (1) JP2002512191A (en)
KR (1) KR20010042765A (en)
CN (1) CN1299283A (en)
AU (1) AU750645B2 (en)
BR (1) BR9909712A (en)
CA (1) CA2328331A1 (en)
EE (1) EE200000601A (en)
HU (1) HUP0101914A3 (en)
IL (1) IL139014A0 (en)
IS (1) IS5663A (en)
IT (1) IT1299161B1 (en)
NO (1) NO20005128L (en)
PL (1) PL343482A1 (en)
SK (1) SK15442000A3 (en)
TR (1) TR200002894T2 (en)
WO (1) WO1999053921A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252309B2 (en) 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
DE10326822A1 (en) * 2003-06-11 2005-01-05 Herzpharma Vita-Check Diagnosegeräte GmbH Dietary supplement, e.g. for increasing general performance, concentration and endurance, comprises NADH, L-carnitine, coenzyme Q10, L-carnosine, succinic acid, ascorbic acid and bioflavonoids
CA2686905C (en) * 2007-05-11 2015-07-07 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Gel useful for the delivery of cosmetic active ingredients
AU2010286348A1 (en) * 2009-08-31 2012-03-22 University Of South Australia Methods for diagnosis and treatment of chronic fatigue syndrome
CN104306390A (en) * 2014-10-23 2015-01-28 苏州人本药业有限公司 Application of reduced coenzyme II
CN104840479A (en) * 2015-02-17 2015-08-19 苏州人本药业有限公司 Application of NADPH in preparation of drugs used for treating heart diseases
US10894059B2 (en) 2017-12-22 2021-01-19 Bontac Bio-Engineering (Shenzhen) Co., Ltd NADH compound composition, and preparation and use thereof
HUE056844T2 (en) 2018-04-20 2022-03-28 Pacotrade Ag Device for crushing deep-frozen foodstuffs provided in block form
CN109170907A (en) * 2018-08-30 2019-01-11 泓博元生命科技（深圳）有限公司 A kind of preparation method of composition containing NMN, application and sports drink
CN109105702A (en) * 2018-08-30 2019-01-01 泓博元生命科技（深圳）有限公司 A kind of preparation method of composition containing NADH, application and energy extender
JP7199518B2 (en) * 2018-10-10 2023-01-05 蘇娥 梁 Health care product composition for deficit compensation, method of making and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054698A (en) * 1964-12-04
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
DE4335454A1 (en) * 1993-10-19 1995-04-20 Schleicher Peter Geriatric medical composition
JPH09110708A (en) * 1995-08-11 1997-04-28 Taisho Pharmaceut Co Ltd Pharmaceutical preparation comprising crude drug for nourishment and robust
JPH0959161A (en) * 1995-08-23 1997-03-04 Taisho Pharmaceut Co Ltd Fatigue improving composition
IT1277953B1 (en) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITION CONTAINING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND A 3-OMEGA SERIES POLYUNSATURED ACID USEFUL
IT1283951B1 (en) * 1996-03-15 1998-05-07 Mendes Srl USE OF ACETYL L-CARNITINE OR ITS PHARMACOLOGICALLY ACCEPTABLE SALTS FOR THERAPEUTIC TREATMENT OR PROPHYLAXIS OF
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
JPH10175856A (en) * 1996-10-14 1998-06-30 Taisho Pharmaceut Co Ltd Fatigue relieving agent

Also Published As

Publication number Publication date
AU750645B2 (en) 2002-07-25
EP1071424A1 (en) 2001-01-31
KR20010042765A (en) 2001-05-25
NO20005128L (en) 2000-12-18
CN1299283A (en) 2001-06-13
ITRM980238A1 (en) 1999-10-17
HUP0101914A3 (en) 2002-12-28
BR9909712A (en) 2000-12-26
TR200002894T2 (en) 2001-01-22
IT1299161B1 (en) 2000-02-29
SK15442000A3 (en) 2001-06-11
HUP0101914A2 (en) 2002-03-28
PL343482A1 (en) 2001-08-27
CA2328331A1 (en) 1999-10-28
IL139014A0 (en) 2001-11-25
JP2002512191A (en) 2002-04-23
IS5663A (en) 2000-10-13
EE200000601A (en) 2002-04-15
AU3442899A (en) 1999-11-08
ITRM980238A0 (en) 1998-04-17
WO1999053921A1 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
NO995784L (en) Phytosterol and / or phytosterol derivatives
NO996491L (en) 4-bromo or 4-iodo-phenylaminobenzhydroxamic acid derivatives and their use as MEK inhibitors
DK1015434T3 (en) New pyrimidin-4-one and pyrimidin-4-thione as fungicide
DK1112005T4 (en) Antioxidant composition comprising acetyl L-carnitine and alpha-lipoic acid
FI981614A (en) Evacuation of bearing condition
NO20006488D0 (en) Composition and application
DK1112003T3 (en) New composition and application
DK0944590T3 (en) Aminoguanidines and alkoxyguanidines as protease inhibitors
DK1012137T3 (en) Aromatic C-16-C-20-substituted tetrahydro-prostaglandins and their use as prostaglandin FP agonists
NO993467D0 (en) Granules comprising clavulanate and one or more excipients
NO984761D0 (en) Aminoisoquinolines and aminotienopyridine derivatives and their use as anti-inflammatory agents
NO20005128L (en) Composition comprising L-carnitine or an alkanoyl-L-carnitine and NADH and / or NADPH
NO994510D0 (en) Substituted isoquinoline derivatives and their use as anticonvulsants
NO995513D0 (en) N-triazolyl-2-indolecarboxamides and their use as CCK-A agonists
NO985891D0 (en) Substituted benzamide derivatives and their use as anticonvulsants
NO986034D0 (en) Combinations comprising VX 478, ZidovudÞn, FTC and / or 3TC for use
NO20012973L (en) Polyester-polyurethane glue and its use
DE69937060D1 (en) IMMUNOGENIC COMPOSITIONS AND ITS USES
MA26666A1 (en) ANTIOXIDE, ANTIPROLIFERATE COMPOSITION, INCLUDING CARNITINE AND CAROTENOIDE.
DK1214302T3 (en) Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones and their use as lipase inhibitors
NO20004904L (en) C11 oxymyl and hydroxylaminoprostaglandins useful as medicaments
NO995308D0 (en) Composition and Methods Using an eutomer
NO20003142D0 (en) Substituted isoquinoline derivatives and their use as anticonvulsants
NO20006626D0 (en) Coating agent and its use
NO20004903L (en) C11 oxymyl and hydroxylaminoprostaglandins useful as FP agonists

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application